King’s Rolls Out Cervical Cancer Self-Sampling Kits
Home-testing kits will be offered for women and people with a cervix who haven’t attended their cervical cancer check, the Government has announced today.
The ground-breaking initiative is informed by evidence provided by the YouScreen trial which was led by King’s College London. The trial, conducted in 2021 by Dr Anita Lim from the Faculty of Life Sciences & Medicine, provided HPV self-sampling kits to women and people with a cervix who were at least six months overdue for their cervical screening. The trial found offering self-sampling kits could boost the numbers screened in England by about 400,000 each year.
Dr Anita Lim, Chief Investigator of the YouScreen trial and Senior Research Fellow, School of Cancer & Pharmaceutical Sciences, said: “This is a significant step forward for cervical cancer prevention and brings us closer to the NHS goal of eliminating the disease by 2040. The YouScreen trial, which provided self-sampling HPV kits to under-screen women in London, demonstrated that self-sampling could reach people who find it difficult to attend traditional screening – including those from diverse and underserved populations.
https://www.kcl.ac.uk/news/kings-research-roll-out-self-sampling-kits-cervical-cancer